NT_1170x120_1-11-18

Steven Anderson

NACDS briefs membership on industry-specific election dynamics

NACDS briefs membership on industry-specific election dynamics

In a memo to NACDS chain and associate members today, NACDS president and chief executive officer Steven Anderson, described detailed results of the 2018 Congressional elections from a pharmacy-specific perspective. The memo described changes in the leadership of key healthcare committees, the election results for Congressional champions of specific pharmacy issues, and other insights. The

NACDS applauds Pennsylvania e-prescribing Law

NACDS applauds Pennsylvania e-prescribing Law

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is applauding the enactment of an electronic prescribing bill (HB 353) in Pennsylvania that will help to prevent opioid abuse. Pennsylvania Gov. Tom Wolf (D) signed the legislation yesterday. The new law requires that all controlled substance prescriptions be electronically prescribed, with certain exceptions. The law takes

NACDS at White House to mark “historic action” on opioid abuse epidemic

NACDS at White House to mark “historic action” on opioid abuse epidemic

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) was invited to a White House event today titled “A Year of Historic Action to Combat the Opioid Crisis,” at which the President signed the SUPPORT for Patients and Communities Act (H.R. 6) – legislation that reflects aspects of all four of NACDS’ policy recommendations regarding opioid-abuse prevention.

NACDS invited to White House event on October 24

NACDS invited to White House event on October 24

ARLINGTON, Va. — NACDS has been invited back to the White House for an event on Wednesday, October 24, that is titled “A Year of Historic Action to Combat the Opioid Crisis.” We also anticipate soon President Trump’s signing of the SUPPORT for Patients and Communities Act – which reflects aspects of all four of the policy

NACDS participates in signing of “gag clause” bills

NACDS participates in signing of “gag clause” bills

ARLINGTON, Va. – At the invitation of the White House, the National Association of Chain Drug Stores (NACDS) today participated with President Trump in the signing ceremony for the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553). Representing NACDS at the ceremony were NACDS vice chairman

U.S. Senate passes NACDS policy recommendations in Opioid Bill

U.S. Senate passes NACDS policy recommendations in Opioid Bill

ARLINGTON, Va. – This week the U.S. Senate passed the opioid-abuse-prevention legislation that reflects aspects of all four of the policy topics recommended by the National Association of Chain Drug Stores (NACDS), and that the U.S. House of Representatives passed on September 28. The bill now goes to President Trump for consideration, and the White House

NACDS to co-host workshop on healthy equity at APHA Expo

NACDS to co-host workshop on healthy equity at APHA Expo

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS), the American Public Health Association (APHA) and the CDC Foundation will host a pre-conference workshop designed to convene public health, pharmacy and health care stakeholders to identify gaps in patient care access, leverage partnerships, and determine practices for improved population health outcomes. The forum

House passes NACDS policy recommendations in Opioid Bill

House passes NACDS policy recommendations in Opioid Bill

ARLINGTON, Va. – The opioid-abuse-prevention legislation crafted by U.S. Senate and U.S. House of Representatives negotiators reflects aspects of all four of the policy topics recommended by the National Association of Chain Drug Stores (NACDS). The House passed the bill today, and the Senate anticipates voting next week. The SUPPORT for Patients and Communities Act (H.R. 6) includes the

NACDS praises Massachusetts e-prescribing Law

NACDS praises Massachusetts e-prescribing Law

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is recognizing the leadership of the Massachusetts state legislature, under the leadership of House Speaker Robert DeLeo (D) and Senate President Karen Spilka (D), along with Governor Charlie Baker (R), for the enactment of House Bill 4742. The new law requires that on or after January 1,

NACDS promoting National Immunization Awareness Month

NACDS promoting National Immunization Awareness Month

During the commemoration of National Immunization Awareness Month in August, NACDS will be promoting a host of story lines of importance to public health and to pharmacy’s role as the face of neighborhood healthcare. The past decade has seen tremendous advancement for pharmacy’s role in protecting Americans with vaccinations. To provide the background, it was

NACDS praises Senate panel’s action on bill to end “gag clauses”

NACDS praises Senate panel’s action on bill to end “gag clauses”

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today welcomed the Senate Health, Education, Labor and Pensions Committee’s passage of the Patient Right to Know Drug Prices Act (S. 2554). In a letter endorsing the legislation, NACDS wrote, “NACDS believes gag clauses should not be allowed in contracts between health plans and

NACDS addresses DIR fees, other “access agenda” priorities

NACDS addresses DIR fees, other “access agenda” priorities

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues. “We believe there are numerous opportunities to achieve the goals of lowering the financial burdens on patients and making prescription drugs more

NACDS RxIMPACT rallies senate support for action on DIR fees

NACDS RxIMPACT rallies senate support for action on DIR fees

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S. Secretary of Health and Human Services Secretary Alex Azar on direct and indirect remuneration (DIR) fee reform in Medicare Part D. NACDS RxIMPACT pharmacy advocates are urging Senators to

1 2 3